Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status - Eisenhofer, G; Lenders, J W; Siegert, G (Eur J Cancer, 2012)
et al.